Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H21N3S |
| Molecular Weight | 347.477 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C[C@H](CSC2=CC=CC=N2)C=C3[C@H]1CC4=CNC5=C4C3=CC=C5
InChI
InChIKey=VCRAKEDGLIINLR-AUUYWEPGSA-N
InChI=1S/C21H21N3S/c1-24-12-14(13-25-20-7-2-3-8-22-20)9-17-16-5-4-6-18-21(16)15(11-23-18)10-19(17)24/h2-9,11,14,19,23H,10,12-13H2,1H3/t14-,19-/m1/s1
| Molecular Formula | C21H21N3S |
| Molecular Weight | 347.477 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Tiomergine is an ergot alkaloid derivative. It is the agonist of the postulated presynaptic dopamine receptor. Tiomergine is the antiparkinsonian agent. Tiomergine modified brain glucose metabolism in a way similar to the neuroleptics but different from postsynaptic agonists. It was ineffective in the treatment of tardive dyskinesia.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Presynaptic dopaminergic agonists modify brain glucose metabolism in a way similar to the neuroleptics. | 1984-09-07 |
|
| Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia. | 1980-04 |
|
| Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects. | 1980 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:54:31 GMT 2025
by
admin
on
Mon Mar 31 17:54:31 GMT 2025
|
| Record UNII |
85J22V47HN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000077231
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
DTXSID901024153
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104731
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
C152639
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
4640
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
SUB11085MIG
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
57935-49-6
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
85J22V47HN
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY | |||
|
9884658
Created by
admin on Mon Mar 31 17:54:31 GMT 2025 , Edited by admin on Mon Mar 31 17:54:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |